웹2024년 11월 3일 · January 5, 2024 웹2024년 6월 4일 · Baird bewertet die Aktie positiv mit einem Kauf-Rating. 18 Juli 2024
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
웹2024년 6월 6일 · For Editas Medicine stock forecast for 2024, 10 predictions are offered for each month of 2024 with average Editas Medicine stock forecast of $9.58, a high forecast … 웹2024년 11월 3일 · Baird analyst Madhu Kumar initiates coverage on Editas Medicine (NASDAQ:EDIT) with a Underperform rating and announces Price Target of $14. the hatcher family dairy nat geo
Editas Medicine to Participate in Upcoming Investor
웹2024년 8월 3일 · CAMBRIDGE, Mass., Aug. 03, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today reported … 웹2024년 11월 18일 · Baird is positief over het aandeel met een koopadvies. Voorheen bedroeg het koersdoel 25 USD, maar is nu verlaagd naar 18 USD. 22 januari 2024 웹2024년 11월 26일 · 6 The Cole Train Connection. When it comes to the dynamic between Cole and Baird, there's a bit more to it than you might think, given their diverging personalities. For one, the roles of the two men were actually going to be reversed in the conceptualization phase, with Baird as the former sports star. Speaking of which - you may have noticed ... the hatchery u of t